Clinicopathologic and prognostic differences between patients with hepatitis B- and C-related resectable hepatocellular carcinoma

Journal of the Formosan Medical Association

Volumn 100, Issue 7, 2001, Pages 443-448

  Chen, T H ^a   Tseng, L M ^a   Chau, G Y ^a   Lui, W Y ^a   Tsay, S H ^a   King, K L ^a   Loong, C C ^a   Hsia, C Y ^a   Wu, C W ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

DNA flow cytometry; Hepatic resection; Hepatitis B; Hepatitis C; Hepatocellular carcinoma; Proliferative activity

Indexed keywords

DNA; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY;

ADULT; AGE; ARTICLE; BLOOD TRANSFUSION; CANCER INCIDENCE; CANCER STAGING; CARCINOGENESIS; CELL PROLIFERATION; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FAMILIAL INCIDENCE; FEMALE; FLOW CYTOMETRY; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER FUNCTION; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MULTIPLE CANCER; PATHOLOGY; PROGNOSIS; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR VOLUME;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPATECTOMY; HEPATITIS B SURFACE ANTIGENS; HEPATITIS C ANTIBODIES; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL RATE;

EID: 0034821982     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Surgical treatment and outcome in patients with a hepatocellular carcinoma greater than 10 cm in diameter
2. Hepatectomy for hepatitis B-, hepatitis C-, and dual hepatitis B- and C-related hepatocellular carcinoma in Taiwan
3. Surgical results in patients with dual hepatitis B- and C-related hepatocellular carcinoma compared with hepatitis B- or C-related hepatocellular carcinoma
4. Hepatitis C virus infection in an area hyperendemic for hepatitis B and chronic liver disease: The Taiwan experience
5. The prevalence of anti-hepatitis C virus among Chinese patients with hepatocellular carcinoma
6. Changes in the prevalence of hepatitis B and C infection in patients with hepatocellular carcinoma in the Nagasaki Prefecture, Japan
7. Prevalence of HBV and HCV infection in Japanese patients with hepatocellular carcinoma
8. Structural rearrangement of integrated hepatitis B virus DNA as well as cellular flanking DNA is present in chronically infected hepatic tissues
9. Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice
10. A transactivating function encoded in the hepatitis B virus X gene is conserved in the integrated state
11. Identification of a region within the human immunodeficiency virus type I long terminal repeat that is essential for transactivation by the hepatitis B virus gene X
12. Predictable factors for estimating prognosis of patients after resection of hepatocellular carcinoma
13. Correlation of hepatitis virus serological status with clinicopatholgic features in patients undergoing hepatectomy for hepatocellular carcinoma
14. A comparison of the surgical results in patients with hepatitis B versus hepatitis C-related hepatocellular carcinoma
15. Hepatic segmentectomy for curative resection of primary hepatocellular carcinoma
16. Operative approaches to hepatocellular carcinoma in the cirrhotic patients
17. Risk factors linked to tumor recurrence of human hepatocellular carcinoma after hepatic resection
18. Nonparametric estimation from incomplete observation
19. Hepatitis B viral marker in patients with chronic hepatitis and with primary hepatocellular carcinoma in Taiwan
20. Hepatitis associated antigen and hepatocellular carcinoma in Taiwan
21. Seroepidemiology of hepatitis C virus infection in Taiwan
22. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis
23. Hepatitis C virus anti-bodies among risk groups in Spain
24. Antibody to hepatitis C virus in German blood donors
25. A comparison of the surgical results in patients with hepatitis B versus hepatitis C-related hepatocellular carcinoma
26. Comparison of the characteristics of hepatocellular carcinoma between hepatitis B and C viral infection: Tumor multicentricity in cirrhotic liver with hepatitis C
27. Comparison of clinical features and survival in patients with hepatitis B and C virus-related hepatocellular carcinoma
28. Difference of resected hepatocellular carcinoma with hepatitis B or C virus
29. Clinical impact of screening first degree relatives of patients with hepatocellular carcinoma
30. Hepatitis B virus infection
31. Prevalence of anti-HCV antibody in blood donors in the Tokyo area
32. Antihepatitis C virus status in hepatocellular carcinoma and the influence on clinicopathological findings and operative results
33. The pathology of hepatitis C
34. The role of hepatic C virus in hepatocellular carcinoma in Japan
35. Can determination of the proliferative capacity of the nontumor portion predict the risk of tumor recurrence in the liver remnant after resection of human hepatocellular carcinoma?
36. Clonal analysis of regenerative nodules in hepatitis C virus-induced liver cirrhosis